425: Strive & Semler Merger: Cautionary Statement on Risks

Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statement risks.

Summary

• This is a Form 425 communication from Strive, Inc. concerning its proposed business combination with Semler Scientific, Inc.
• The communication was posted on X.com by Strive, Inc.'s account on December 4, 2025.
• It serves as a cautionary statement regarding forward-looking statements related to the proposed transaction, as defined by the Private Securities Litigation Reform Act of 1995.
• Forward-looking statements include expectations about the transaction's outlook, strategic and financial benefits, impact on future financial performance, timing of closing, and successful integration of the combined businesses.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4, Information Statement/Proxy Statement/Prospectus, and other relevant SEC filings before making voting or investment decisions.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement for a proposed merger, presenting both anticipated benefits and a comprehensive list of risks. The tone is neutral and factual, as required for SEC disclosures, but the extensive list of risks introduces a degree of caution.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits are expected from the proposed transaction.
• The combined company anticipates cost savings and strategic gains.

Risks

• The occurrence of any event, change, or circumstance that could give rise to the right of one or both of Strive and Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing discusses the outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including anticipated strategic and financial benefits, the expected impact on future financial performance, the timing of closing, and the ability to successfully integrate the combined businesses. However, it heavily cautions that actual results may differ materially from these forward-looking statements due to various inherent risks and uncertainties.

Management Comments

• No direct quotes from management are provided in this communication. The filing refers to 'opinions or judgments of Strive, Semler Scientific and/or their respective management about future events.'

Industry Context

This filing is a procedural communication related to a specific corporate merger between Strive, Inc. and Semler Scientific, Inc. and does not provide broader industry trend analysis.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Dilution for existing Strive shareholders due to the issuance of new Class A common stock.

Next Steps

• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any amendments or supplements.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury Strategy, Digital Assets, Corporate Governance